Clinical Trial Update: Co-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic Patients [NA]

View source ↗

Summary

Completed clinical trial evaluating co-treatment with pegvisomant and a somatostatin analogue in acromegaly patients with insulin resistance. The snippet does n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acromegaly
• Impaired Glucose Tolerance
• Insulin Resistance

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)
• Pegvisomant (pegvisomant)

Snippet

Sponsor: University of Aarhus | Conditions: Acromegaly, Insulin Resistance | NA | Status: COMPLETED